Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Karuna Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 159 | 0 |
| Shares | 25.8M | 422.6K | 25.7M | +309.4K (+1.2%) |
| Value | $2.93B | $48.2M | $3.13B | +$249.9M (+8.7%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Karuna Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 345,371 | $42.2M | 0.05% |
| Sands Capital Ventures, LLC | 267,895 | $32.8M | 4.94% |
| Jennison Associates LLC | 88,341 | $10.8M | 0.01% |
| Kiwi Wealth Investments Limited Partnership | 47,500 | $5.81M | 0.30% |
| Eversept Partners, LP | 25,000 | $3.06M | 0.25% |
| Millennium Management LLC | 22,348 | $2.73M | 0.00% |
| Tudor Investment Corp Et Al | 9,906 | $1.21M | 0.02% |
| OneAscent Wealth Management LLC | 1,995 | $244.0K | 0.28% |
| Janus Henderson Group PLC | 1,916 | $235.0K | 0.00% |
| Caption Management, LLC | 1,700 | $208.0K | 0.01% |
| Smith Group Asset Management, LLC | 20 | $2.00K | 0.00% |
| Signaturefd, LLC | 7 | $1.00K | 0.00% |
Sold out (12)
Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sands Capital Management, LLC | 380,307 | $43.4M |
| Holocene Advisors, LP | 201,754 | $23.0M |
| Capital International Inc | 190,923 | $21.8M |
| Maven Securities LTD | 50,000 | $5.72M |
| Caas Capital Management LP | 20,511 | $2.34M |
| FIL Ltd | 16,491 | $1.88M |
| Susquehanna Fundamental Investments, LLC | 5,867 | $669.0K |
| Qube Research & Technologies Ltd | 5,095 | $581.0K |
| Virtu Financial LLC | 4,081 | $465.0K |
| Squarepoint Ops LLC | 2,729 | $311.0K |
| Advisory Services Network, LLC | 7 | $1.00K |
| Rockefeller Capital Management L.P. | 9 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Karuna Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 422,554 | $48.2M |